SkinSpirit Launches PDRN Salmon DNA Regenerative Treatment
SEATTLE, July 1, 2026 SkinSpirit, a leading U.S. provider of medical aesthetic treatments, has expanded its regenerative aesthetics portfolio...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
SEATTLE, July 1, 2026 SkinSpirit, a leading U.S. provider of medical aesthetic treatments, has expanded its regenerative aesthetics portfolio...
IRVINE, Calif., June 16, 2026 Allergan Aesthetics, an AbbVie company, has received U.S. Food and Drug Administration (FDA) approval...
SCOTTSDALE, Ariz., June 1, 2026 PCA SKIN®, a globally recognized leader in professional skincare and chemical peel innovation, has...
DALLAS, Feb. 20, 2026 — Revision Skincare® announced that its DEJ Daily Boosting Serum™ has been named Winner in...
LONDON, UK – January 7, 2026 — iSMART Developments Ltd., a UK-based innovator in LED light-based skincare, aesthetics, and...
